GilbarPDooleyMBrienJ. Inadvertent intrathecal administration of vincristine: are we fulfilling our roles as oncology pharmacists?. J Oncol Pharm Pract2004; 10: 187–189.
2.
ReddyGKBrownBNandaA. Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine?. Clin Neurol Neurosurg2011; 113: 68–71.
3.
PongudomSChinthammitrY. Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature. J Med Assoc Thai2011; 94(Suppl 1): S1–6.
4.
GilbarPDooleyM. Review of case reports of inadvertent intrathecal administration of vincristine: Recommendations to reduce occurrence. Asia Pacific J Clin Oncol2007; 3: 59–65.
5.
Hong Kong Hospital Authority. ‘Report on a medication incident of intrathecal administration of vincristine in Prince of Wales hospital’, Online Referencing Special Investigation Panel2007, http://www.ha.org.hk/investigation_panel/pwh/report_eng.pdf (2007, accessed December 2010).
6.
D’AddarioAGaluppoJNavariCSchultzMCuelloNTroncosoJC. Accidental intrathecal administration of vincristine. Am J Forensic Med Pathol2010; 31: 83–84.
HennipmanBde VriesEBokkerinkJPMBallLMVeermanAJP. Intrathecal vincristine: 3 fatal cases and a review of the literature. J Pediatr Hematol Oncol2009; 31: 816–819.
